Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Vytelle LLC is active in the Chemistry & Materials technology area with 1 pending office action currently under review. This action is being managed by 1 distinct examiner, LIMBAUGH, KATHRYN ELIZABETH. As the busiest examiner for this portfolio, LIMBAUGH, KATHRYN ELIZABETH is responsible for the 1 pending office action. This indicates a concentrated effort on a specific chemical or material innovation.
The examination is taking place in 1 distinct art unit, which points to a specialized technical focus for the applicant. With 1 distinct examiner and 1 distinct art unit, the prosecution process is highly focused. The outcome of the 1 pending office action will be the primary factor in the portfolio's progress in the Chemistry & Materials space. Because LIMBAUGH, KATHRYN ELIZABETH is the only examiner involved, the applicant can dedicate resources to addressing the specific requirements of this 1 pending office action. This 1 distinct art unit provides the administrative framework for the current prosecution phase, allowing for a direct and targeted legal strategy to move the application toward allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEVI, SARVAMANGALA | 1 | 65.3% | +55.3% |
| LIMBAUGH, KATHRYN ELIZABETH | 1 | 76.0% | +31.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18626627 | MICROBIOME TREATMENTS FOR ANIMAL FERTILITY | DEVI, SARVAMANGALA | — |
| 18508448 | VAGINAL LIPID PROFILES PREDICTIVE OF SUCCESSFUL OR UNSUCCESSFUL PREGNANCY IN A BOVINE SURROGATE DAM FOLLOWING EMBRYO TRANSFER | LIMBAUGH, KATHRYN ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18626627 | MICROBIOME TREATMENTS FOR ANIMAL FERTILITY | DEVI, SARVAMANGALA | — |
| 18508448 | VAGINAL LIPID PROFILES PREDICTIVE OF SUCCESSFUL OR UNSUCCESSFUL PREGNANCY IN A BOVINE SURROGATE DAM FOLLOWING EMBRYO TRANSFER | LIMBAUGH, KATHRYN ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18626627 | MICROBIOME TREATMENTS FOR ANIMAL FERTILITY | DEVI, SARVAMANGALA | 1645 | §102§103§112 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18508448 | VAGINAL LIPID PROFILES PREDICTIVE OF SUCCESSFUL OR UNSUCCESSFUL PREGNANCY IN A BOVINE SURROGATE DAM FOLLOWING EMBRYO TRANSFER | LIMBAUGH, KATHRYN ELIZABETH | 1797 | §103§112 | Non-Final OA | — | Pending | Nov 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial